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We are in the middle of a paradigm shift in bacterial
infectious diseases. Thus, bacteria in their pathogenic role
have, for now, been deﬁned at the species level. There has
been, moreover, confusion in the taxonomy. Indeed, doctors
want to name bacteria, agents or epidemic diseases with a
speciﬁc species name, whereas taxonomists focus on other
elements, including genetic, metabolic and morphological
factors. For example, the agent of typhoid fever, Salmonella
typhi, ﬁnally lost its species name, whereas it corresponds to
a pathovar, which doctors need to name. Thus, the former
Salmonella typhi, which should be called, according to genetic
deﬁnitions, Salmonella enterica serotype typhi, is now written
Salmonella Typhi, as a compromise between medical doctors
and taxonomists [1].
The situation is the same for many bacterial agents of
disease that are, in fact, microbial clones. The continuous
emergence of new virulent microbial clones among popula-
tions of pathogenic, or non-pathogenic, bacteria is a major
element that genomics now allows the study of. Several
studies are presented in this issue; the work of Wren [2] on
Clostridium difﬁcile shows that a particularly dangerous clone,
O27, appeared a few years ago and has been spreading
across the planet, with greater infectiousness and mortality
than others. Thus, the detection of O27 has become
essential, to enable adequate measures to be taken. Another
clear example is the Beijing genotype of Mycobacterium
tuberculosis, recent work on which has been published in
the journal [3]; it appeared 30 years ago as the epidemic
clone of M. tuberculosis capable of carrying multiple resistance
determinants, and now represents 10% of M. tuberculosis
isolates worldwide.
Most other clones have an endemic dissemination and
represent very contagious microorganisms; there is a tuber-
culosis pandemic linked to Beijing whose distribution and
severity are very different from those of other older clones of
M. tuberculosis.
The situation is the same for plague: it has been shown
through palaeomicrobiology studies of the Justinian plague,
then the plague of the Middle Ages [4], that the three major
pandemics corresponded to particularly virulent Yersinia pestis
clones that diffused at high speed through different conti-
nents.
For the work on Neisseria meningitidis reported by Read [5],
a genomic surprise was that the clone currently circulating in
the UK could be either serotype A or serotype C, which
challenges our classiﬁcation of N. meningitidis and may change
vaccine strategies. Indeed, if the vaccine strategies of encircle-
ment are based on the identiﬁcation of the serotype, it will not
be possible to control the epidemics.
Moreover, regarding cholera genomics, studies have
shown that, in the midst of a very large population of Vibrio
cholerae existing in the environment, only a few clones have
the potential to spread and generate epidemics and pandem-
ics. For example, the observed epidemic in Haiti was caused
by a virulent and pathogenic clone already detected in Nepal
and carried by Nepalese United Nations’soldiers; this
triggered an extremely deadly epidemic, and it is the same
clone, and not multiple clones, in the environment of Haiti
[6].
Finally, multiple clones will continue to appear in our
environment. This was the case, for example, with Escherichia
coli in a German outbreak of severe gastroenteritis, which
was also clariﬁed, thanks to the identiﬁcation of a speciﬁc
genomic clone [7]. This is also the case for E. coli clones
responsible for urinary tract infections and resistant exclu-
sively to co-trimoxazole [7]. Finally, other clones will appear
that are capable of generating epidemics, such the clone
detected in Sweden of Chlamydia trachomatis [8], which
escaped detection with molecular diagnostic techniques by
presenting a mutation of the gene that is most commonly
used for PCR!
In total, our understanding of epidemics of bacterial
origin is being substantially increased by genomics,
which shows us that most epidemics are caused by
individual clones that merit a speciﬁc identiﬁcation and
require us to redeﬁne particular isolation and preventive
measures because of their epidemic and pathological
speciﬁcity.
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